Eastside Lansing biotech firm, Neogen Corp., recently reported more than $100 million in revenue, setting a new record for the food safety company.
According to excerpts from the article:
"We all do take pride in reaching the achievement of the $100 million level," said James Herbert, Neogen's chairman and chief executive officer. "But I can assure you we won't spend much time basking in that."
Neogen reported Tuesday it earned $12.1 million, or 81 cents per diluted share, for the fiscal year that ended May 31. That was up nearly 33 percent from a year earlier, when Neogen earned $9.13 million, or 64 cents per diluted share.
Revenue grew nearly 19 percent to $102.42 million. That was up from $86.14 million the previous fiscal year.
Read the entire article here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.